Request for Covid-19 Impact Assessment of this Report
The United States Antibody market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Antibody market, reaching US$ million by the year 2028. As for the Europe Antibody landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Antibody players cover Roche, Johnson and Johnson, Merck, and Novartis, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Antibody market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
IgM
IgG
IgA
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Therapeutic
Research
Diagnostic
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Roche
Johnson and Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antibody Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Antibody by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Antibody by Country/Region, 2017, 2022 & 2028
2.2 Antibody Segment by Type
2.2.1 IgM
2.2.2 IgG
2.2.3 IgA
2.2.4 Other
2.3 Antibody Sales by Type
2.3.1 Global Antibody Sales Market Share by Type (2017-2022)
2.3.2 Global Antibody Revenue and Market Share by Type (2017-2022)
2.3.3 Global Antibody Sale Price by Type (2017-2022)
2.4 Antibody Segment by Application
2.4.1 Therapeutic
2.4.2 Research
2.4.3 Diagnostic
2.5 Antibody Sales by Application
2.5.1 Global Antibody Sale Market Share by Application (2017-2022)
2.5.2 Global Antibody Revenue and Market Share by Application (2017-2022)
2.5.3 Global Antibody Sale Price by Application (2017-2022)
3 Global Antibody by Company
3.1 Global Antibody Breakdown Data by Company
3.1.1 Global Antibody Annual Sales by Company (2020-2022)
3.1.2 Global Antibody Sales Market Share by Company (2020-2022)
3.2 Global Antibody Annual Revenue by Company (2020-2022)
3.2.1 Global Antibody Revenue by Company (2020-2022)
3.2.2 Global Antibody Revenue Market Share by Company (2020-2022)
3.3 Global Antibody Sale Price by Company
3.4 Key Manufacturers Antibody Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antibody Product Location Distribution
3.4.2 Players Antibody Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Antibody by Geographic Region
4.1 World Historic Antibody Market Size by Geographic Region (2017-2022)
4.1.1 Global Antibody Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Antibody Annual Revenue by Geographic Region
4.2 World Historic Antibody Market Size by Country/Region (2017-2022)
4.2.1 Global Antibody Annual Sales by Country/Region (2017-2022)
4.2.2 Global Antibody Annual Revenue by Country/Region
4.3 Americas Antibody Sales Growth
4.4 APAC Antibody Sales Growth
4.5 Europe Antibody Sales Growth
4.6 Middle East & Africa Antibody Sales Growth
5 Americas
5.1 Americas Antibody Sales by Country
5.1.1 Americas Antibody Sales by Country (2017-2022)
5.1.2 Americas Antibody Revenue by Country (2017-2022)
5.2 Americas Antibody Sales by Type
5.3 Americas Antibody Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antibody Sales by Region
6.1.1 APAC Antibody Sales by Region (2017-2022)
6.1.2 APAC Antibody Revenue by Region (2017-2022)
6.2 APAC Antibody Sales by Type
6.3 APAC Antibody Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Antibody by Country
7.1.1 Europe Antibody Sales by Country (2017-2022)
7.1.2 Europe Antibody Revenue by Country (2017-2022)
7.2 Europe Antibody Sales by Type
7.3 Europe Antibody Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Antibody by Country
8.1.1 Middle East & Africa Antibody Sales by Country (2017-2022)
8.1.2 Middle East & Africa Antibody Revenue by Country (2017-2022)
8.2 Middle East & Africa Antibody Sales by Type
8.3 Middle East & Africa Antibody Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antibody
10.3 Manufacturing Process Analysis of Antibody
10.4 Industry Chain Structure of Antibody
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antibody Distributors
11.3 Antibody Customer
12 World Forecast Review for Antibody by Geographic Region
12.1 Global Antibody Market Size Forecast by Region
12.1.1 Global Antibody Forecast by Region (2023-2028)
12.1.2 Global Antibody Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Antibody Forecast by Type
12.7 Global Antibody Forecast by Application
13 Key Players Analysis
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Antibody Product Offered
13.1.3 Roche Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Johnson and Johnson
13.2.1 Johnson and Johnson Company Information
13.2.2 Johnson and Johnson Antibody Product Offered
13.2.3 Johnson and Johnson Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Johnson and Johnson Main Business Overview
13.2.5 Johnson and Johnson Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Antibody Product Offered
13.3.3 Merck Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Novartis
13.4.1 Novartis Company Information
13.4.2 Novartis Antibody Product Offered
13.4.3 Novartis Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Novartis Main Business Overview
13.4.5 Novartis Latest Developments
13.5 AbbVie
13.5.1 AbbVie Company Information
13.5.2 AbbVie Antibody Product Offered
13.5.3 AbbVie Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 AbbVie Main Business Overview
13.5.5 AbbVie Latest Developments
13.6 Amgen
13.6.1 Amgen Company Information
13.6.2 Amgen Antibody Product Offered
13.6.3 Amgen Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Amgen Main Business Overview
13.6.5 Amgen Latest Developments
13.7 Pfizer
13.7.1 Pfizer Company Information
13.7.2 Pfizer Antibody Product Offered
13.7.3 Pfizer Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Pfizer Main Business Overview
13.7.5 Pfizer Latest Developments
13.8 Bayer
13.8.1 Bayer Company Information
13.8.2 Bayer Antibody Product Offered
13.8.3 Bayer Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Bayer Main Business Overview
13.8.5 Bayer Latest Developments
13.9 Lilly
13.9.1 Lilly Company Information
13.9.2 Lilly Antibody Product Offered
13.9.3 Lilly Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Lilly Main Business Overview
13.9.5 Lilly Latest Developments
13.10 Bristol-Myers Squibb
13.10.1 Bristol-Myers Squibb Company Information
13.10.2 Bristol-Myers Squibb Antibody Product Offered
13.10.3 Bristol-Myers Squibb Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Bristol-Myers Squibb Main Business Overview
13.10.5 Bristol-Myers Squibb Latest Developments
13.11 GlaxoSmithKline
13.11.1 GlaxoSmithKline Company Information
13.11.2 GlaxoSmithKline Antibody Product Offered
13.11.3 GlaxoSmithKline Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 GlaxoSmithKline Main Business Overview
13.11.5 GlaxoSmithKline Latest Developments
13.12 Biogen
13.12.1 Biogen Company Information
13.12.2 Biogen Antibody Product Offered
13.12.3 Biogen Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Biogen Main Business Overview
13.12.5 Biogen Latest Developments
13.13 AstraZeneca
13.13.1 AstraZeneca Company Information
13.13.2 AstraZeneca Antibody Product Offered
13.13.3 AstraZeneca Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 AstraZeneca Main Business Overview
13.13.5 AstraZeneca Latest Developments
13.14 Sanofi
13.14.1 Sanofi Company Information
13.14.2 Sanofi Antibody Product Offered
13.14.3 Sanofi Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Sanofi Main Business Overview
13.14.5 Sanofi Latest Developments
13.15 Alexion Pharmaceuticals
13.15.1 Alexion Pharmaceuticals Company Information
13.15.2 Alexion Pharmaceuticals Antibody Product Offered
13.15.3 Alexion Pharmaceuticals Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Alexion Pharmaceuticals Main Business Overview
13.15.5 Alexion Pharmaceuticals Latest Developments
13.16 Seattle Genetics
13.16.1 Seattle Genetics Company Information
13.16.2 Seattle Genetics Antibody Product Offered
13.16.3 Seattle Genetics Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Seattle Genetics Main Business Overview
13.16.5 Seattle Genetics Latest Developments
14 Research Findings and Conclusion
Table 1. Antibody Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Antibody Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of IgM
Table 4. Major Players of IgG
Table 5. Major Players of IgA
Table 6. Major Players of Other
Table 7. Global Antibody Sales by Type (2017-2022) & (KG)
Table 8. Global Antibody Sales Market Share by Type (2017-2022)
Table 9. Global Antibody Revenue by Type (2017-2022) & ($ million)
Table 10. Global Antibody Revenue Market Share by Type (2017-2022)
Table 11. Global Antibody Sale Price by Type (2017-2022) & (USD/KG)
Table 12. Global Antibody Sales by Application (2017-2022) & (KG)
Table 13. Global Antibody Sales Market Share by Application (2017-2022)
Table 14. Global Antibody Revenue by Application (2017-2022)
Table 15. Global Antibody Revenue Market Share by Application (2017-2022)
Table 16. Global Antibody Sale Price by Application (2017-2022) & (USD/KG)
Table 17. Global Antibody Sales by Company (2020-2022) & (KG)
Table 18. Global Antibody Sales Market Share by Company (2020-2022)
Table 19. Global Antibody Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Antibody Revenue Market Share by Company (2020-2022)
Table 21. Global Antibody Sale Price by Company (2020-2022) & (USD/KG)
Table 22. Key Manufacturers Antibody Producing Area Distribution and Sales Area
Table 23. Players Antibody Products Offered
Table 24. Antibody Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Antibody Sales by Geographic Region (2017-2022) & (KG)
Table 28. Global Antibody Sales Market Share Geographic Region (2017-2022)
Table 29. Global Antibody Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Antibody Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Antibody Sales by Country/Region (2017-2022) & (KG)
Table 32. Global Antibody Sales Market Share by Country/Region (2017-2022)
Table 33. Global Antibody Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Antibody Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Antibody Sales by Country (2017-2022) & (KG)
Table 36. Americas Antibody Sales Market Share by Country (2017-2022)
Table 37. Americas Antibody Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Antibody Revenue Market Share by Country (2017-2022)
Table 39. Americas Antibody Sales by Type (2017-2022) & (KG)
Table 40. Americas Antibody Sales Market Share by Type (2017-2022)
Table 41. Americas Antibody Sales by Application (2017-2022) & (KG)
Table 42. Americas Antibody Sales Market Share by Application (2017-2022)
Table 43. APAC Antibody Sales by Region (2017-2022) & (KG)
Table 44. APAC Antibody Sales Market Share by Region (2017-2022)
Table 45. APAC Antibody Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Antibody Revenue Market Share by Region (2017-2022)
Table 47. APAC Antibody Sales by Type (2017-2022) & (KG)
Table 48. APAC Antibody Sales Market Share by Type (2017-2022)
Table 49. APAC Antibody Sales by Application (2017-2022) & (KG)
Table 50. APAC Antibody Sales Market Share by Application (2017-2022)
Table 51. Europe Antibody Sales by Country (2017-2022) & (KG)
Table 52. Europe Antibody Sales Market Share by Country (2017-2022)
Table 53. Europe Antibody Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Antibody Revenue Market Share by Country (2017-2022)
Table 55. Europe Antibody Sales by Type (2017-2022) & (KG)
Table 56. Europe Antibody Sales Market Share by Type (2017-2022)
Table 57. Europe Antibody Sales by Application (2017-2022) & (KG)
Table 58. Europe Antibody Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Antibody Sales by Country (2017-2022) & (KG)
Table 60. Middle East & Africa Antibody Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Antibody Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Antibody Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Antibody Sales by Type (2017-2022) & (KG)
Table 64. Middle East & Africa Antibody Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Antibody Sales by Application (2017-2022) & (KG)
Table 66. Middle East & Africa Antibody Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Antibody
Table 68. Key Market Challenges & Risks of Antibody
Table 69. Key Industry Trends of Antibody
Table 70. Antibody Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Antibody Distributors List
Table 73. Antibody Customer List
Table 74. Global Antibody Sales Forecast by Region (2023-2028) & (KG)
Table 75. Global Antibody Sales Market Forecast by Region
Table 76. Global Antibody Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Antibody Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Antibody Sales Forecast by Country (2023-2028) & (KG)
Table 79. Americas Antibody Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Antibody Sales Forecast by Region (2023-2028) & (KG)
Table 81. APAC Antibody Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Antibody Sales Forecast by Country (2023-2028) & (KG)
Table 83. Europe Antibody Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Antibody Sales Forecast by Country (2023-2028) & (KG)
Table 85. Middle East & Africa Antibody Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Antibody Sales Forecast by Type (2023-2028) & (KG)
Table 87. Global Antibody Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Antibody Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Antibody Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Antibody Sales Forecast by Application (2023-2028) & (KG)
Table 91. Global Antibody Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Antibody Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Antibody Revenue Market Share Forecast by Application (2023-2028)
Table 94. Roche Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 95. Roche Antibody Product Offered
Table 96. Roche Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2022)
Table 97. Roche Main Business
Table 98. Roche Latest Developments
Table 99. Johnson and Johnson Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 100. Johnson and Johnson Antibody Product Offered
Table 101. Johnson and Johnson Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2022)
Table 102. Johnson and Johnson Main Business
Table 103. Johnson and Johnson Latest Developments
Table 104. Merck Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 105. Merck Antibody Product Offered
Table 106. Merck Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2022)
Table 107. Merck Main Business
Table 108. Merck Latest Developments
Table 109. Novartis Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 110. Novartis Antibody Product Offered
Table 111. Novartis Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2022)
Table 112. Novartis Main Business
Table 113. Novartis Latest Developments
Table 114. AbbVie Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 115. AbbVie Antibody Product Offered
Table 116. AbbVie Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2022)
Table 117. AbbVie Main Business
Table 118. AbbVie Latest Developments
Table 119. Amgen Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 120. Amgen Antibody Product Offered
Table 121. Amgen Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2022)
Table 122. Amgen Main Business
Table 123. Amgen Latest Developments
Table 124. Pfizer Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 125. Pfizer Antibody Product Offered
Table 126. Pfizer Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2022)
Table 127. Pfizer Main Business
Table 128. Pfizer Latest Developments
Table 129. Bayer Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 130. Bayer Antibody Product Offered
Table 131. Bayer Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2022)
Table 132. Bayer Main Business
Table 133. Bayer Latest Developments
Table 134. Lilly Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 135. Lilly Antibody Product Offered
Table 136. Lilly Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2022)
Table 137. Lilly Main Business
Table 138. Lilly Latest Developments
Table 139. Bristol-Myers Squibb Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 140. Bristol-Myers Squibb Antibody Product Offered
Table 141. Bristol-Myers Squibb Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2022)
Table 142. Bristol-Myers Squibb Main Business
Table 143. Bristol-Myers Squibb Latest Developments
Table 144. GlaxoSmithKline Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 145. GlaxoSmithKline Antibody Product Offered
Table 146. GlaxoSmithKline Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2022)
Table 147. GlaxoSmithKline Main Business
Table 148. GlaxoSmithKline Latest Developments
Table 149. Biogen Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 150. Biogen Antibody Product Offered
Table 151. Biogen Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2022)
Table 152. Biogen Main Business
Table 153. Biogen Latest Developments
Table 154. AstraZeneca Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 155. AstraZeneca Antibody Product Offered
Table 156. AstraZeneca Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2022)
Table 157. AstraZeneca Main Business
Table 158. AstraZeneca Latest Developments
Table 159. Sanofi Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 160. Sanofi Antibody Product Offered
Table 161. Sanofi Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2022)
Table 162. Sanofi Main Business
Table 163. Sanofi Latest Developments
Table 164. Alexion Pharmaceuticals Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 165. Alexion Pharmaceuticals Antibody Product Offered
Table 166. Alexion Pharmaceuticals Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2022)
Table 167. Alexion Pharmaceuticals Main Business
Table 168. Alexion Pharmaceuticals Latest Developments
Table 169. Seattle Genetics Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 170. Seattle Genetics Antibody Product Offered
Table 171. Seattle Genetics Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2022)
Table 172. Seattle Genetics Main Business
Table 173. Seattle Genetics Latest Developments
List of Figures
Figure 1. Picture of Antibody
Figure 2. Antibody Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antibody Sales Growth Rate 2017-2028 (KG)
Figure 7. Global Antibody Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Antibody Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of IgM
Figure 10. Product Picture of IgG
Figure 11. Product Picture of IgA
Figure 12. Product Picture of Other
Figure 13. Global Antibody Sales Market Share by Type in 2021
Figure 14. Global Antibody Revenue Market Share by Type (2017-2022)
Figure 15. Antibody Consumed in Therapeutic
Figure 16. Global Antibody Market: Therapeutic (2017-2022) & (KG)
Figure 17. Antibody Consumed in Research
Figure 18. Global Antibody Market: Research (2017-2022) & (KG)
Figure 19. Antibody Consumed in Diagnostic
Figure 20. Global Antibody Market: Diagnostic (2017-2022) & (KG)
Figure 21. Global Antibody Sales Market Share by Application (2017-2022)
Figure 22. Global Antibody Revenue Market Share by Application in 2021
Figure 23. Antibody Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Antibody Revenue Market Share by Company in 2021
Figure 25. Global Antibody Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Antibody Revenue Market Share by Geographic Region in 2021
Figure 27. Global Antibody Sales Market Share by Region (2017-2022)
Figure 28. Global Antibody Revenue Market Share by Country/Region in 2021
Figure 29. Americas Antibody Sales 2017-2022 (KG)
Figure 30. Americas Antibody Revenue 2017-2022 ($ Millions)
Figure 31. APAC Antibody Sales 2017-2022 (KG)
Figure 32. APAC Antibody Revenue 2017-2022 ($ Millions)
Figure 33. Europe Antibody Sales 2017-2022 (KG)
Figure 34. Europe Antibody Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Antibody Sales 2017-2022 (KG)
Figure 36. Middle East & Africa Antibody Revenue 2017-2022 ($ Millions)
Figure 37. Americas Antibody Sales Market Share by Country in 2021
Figure 38. Americas Antibody Revenue Market Share by Country in 2021
Figure 39. United States Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Antibody Sales Market Share by Region in 2021
Figure 44. APAC Antibody Revenue Market Share by Regions in 2021
Figure 45. China Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Antibody Sales Market Share by Country in 2021
Figure 52. Europe Antibody Revenue Market Share by Country in 2021
Figure 53. Germany Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Antibody Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Antibody Revenue Market Share by Country in 2021
Figure 60. Egypt Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Antibody in 2021
Figure 66. Manufacturing Process Analysis of Antibody
Figure 67. Industry Chain Structure of Antibody
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...